Free Trial

Revance Therapeutics (RVNC) Insider Trading & Ownership

Revance Therapeutics logo
$3.08 +0.01 (+0.33%)
(As of 08:58 AM ET)

Revance Therapeutics (NASDAQ:RVNC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.10%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$143,642.48
Get RVNC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Revance Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RVNC Insider Buying and Selling by Quarter

Revance Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/16/2024Erica JordanInsiderSell2,392$3.80$9,089.60  
3/18/2024Dustin S SjutsPresidentSell9,211$5.04$46,423.44  
3/18/2024Dwight MoxieInsiderSell8,125$5.04$40,950.00  
3/18/2024Tobin SchilkeCFOSell9,361$5.04$47,179.44  
(Data available from 1/1/2013 forward)

RVNC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Revance Therapeutics includes Carey Oconnor Kolaja, Dustin S Sjuts, Dwight Moxie, Erica Jordan, Mark J Foley, and Tobin Schilke. Learn more on insiders at RVNC.

5.10% of Revance Therapeutics stock is owned by insiders. Learn more on RVNC's insider holdings.

The following insiders have sold RVNC shares in the last 24 months: Carey Oconnor Kolaja ($70,600.00), Dustin S Sjuts ($1,606,029.41), Dwight Moxie ($1,789,465.12), Erica Jordan ($9,089.60), Mark J Foley ($6,866,970.12), and Tobin Schilke ($1,311,185.19).

Insiders have sold a total of 407,960 Revance Therapeutics shares in the last 24 months for a total of $11,653,339.44 sold.

Revance Therapeutics Key Executives



This page (NASDAQ:RVNC) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners